What Investors Should Pay Attention to in AbbVie's Q3 Earnings Report
28/10 18:46
With AbbVie's (NYSE: ABBV) third-quarter earnings report scheduled for Oct. 29, shareholders and prospective investors should be on alert. AbbVie is in the middle of transitioning its revenue base away from dependence on its blockbuster drug Humira, as its exclusivity protections...